Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-11CUE3Form 3 Filing for Michael Vincent Meluzio at Cue Biopharma, Inc.
This filing is a Form 3, which reports initial beneficial ownership of securities. Michael Vincent Meluzio, identified by CIK 0002138368, is the reporting owner. He is the VP, Principal Accounting Officer of Cue Biopharma, Inc. (CIK 0001645460, trading symbol CUE). The filing indicates he owns 1 security. The report of...
Micro CapBiotechnology
2026-06-11QNCX3Form 3 Filing - Power of Attorney for Brigette Roberts
This filing is an Exhibit 24, a Power of Attorney for Brigette Roberts, Chief Corp. Affairs Officer and Director at Quince Therapeutics, Inc. The document grants Brendan Hannah and Dirk Thye the authority to execute and submit Forms 3, 4, and 5 to the SEC on behalf of Ms. Roberts. This power of attorney is necessary du...
Nano CapBiotechnology
2026-06-11CUE3Form 3 Filing for Cue Biopharma, Inc. - Initial Statement of Beneficial OwnershipMEDIUM
This filing reports on Form 3, an Initial Statement of Beneficial Ownership, for Sumita Ray, identified as a corporate secretary and Chief Legal Compliance Officer of Cue Biopharma, Inc. (CUE). The report details holdings as of June 1, 2026. Ray beneficially owns 54,589 shares of Common Stock directly. Additionally, Ra...
Micro CapBiotechnology
2026-06-11Quince Therapeutics, Inc.3Form 3 Filing - Power of Attorney for Brigette RobertsDuplicate
This filing is an Exhibit 24, a Power of Attorney for Brigette Roberts, Chief Corp. Affairs Officer and Director at Quince Therapeutics, Inc. The document grants Brendan Hannah and Dirk Thye the authority to execute and submit Forms 3, 4, and 5 to the SEC on behalf of Ms. Roberts. This power of attorney is necessary du...
Nano CapBiotechnology
2026-06-11ABCL3Power of Attorney for SEC FilingsMEDIUM
This filing details a Power of Attorney granted by Victor Sandor, a director of AbCellera Biologics Inc., to Tryn Stimart. Ms. Stimart, as Chief Legal and Compliance Officer, is authorized to execute various U.S. Securities and Exchange Commission (SEC) forms on behalf of Mr. Sandor. These forms include Form ID, Form 3...
Small CapBiotechnology